Skip to main content

Advertisement

Table 1 Type of tumor, WHO grading and gender of brain tumors patients

From: Serum and cerebrospinal fluid Neudesin concentration and Neudesin Quotient as potential circulating biomarkers of a primary brain tumor

Type of tumor (WHO grading) Gender
Patients with astrocytic brain tumor
(11 M/9F; mean age 57 ± years, range 39–73 years)
 Diffuse astrocytoma (2) M
 Glioblastoma (4) M
 Anaplastic astrocytoma (4) M
 Glioblastoma (4) M
 Gliosarcoma (4) M
 Glioblastoma (4) M
 Anaplastic glioma (3) M
 Glioblastoma (4) M
 Pilocytic astrocytoma (1) M
 Glioblastoma (4) M
 Glioblastoma (4) M
 Glioblastoma (4) F
 Diffuse astrocytoma (2) F
 Glioblastoma (4) F
 Glioblastoma (4) F
 Glioblastoma (4) F
 Glioblastoma (4) F
 Glioma (4) F
 Glioblastoma (4) F
 Anaplastic astrocytoma (3) F
Patients with tumor of the meninges
(1 M/7F; mean age 54 ± years, range 36–68 years)
 Anaplastic meningioma (3) M
 Transitional meningioma with psammoma bodies (1) F
 Psammomatous meningioma (1) F
 Transitional meningioma (1) F
 Meningothelial meningioma (1) F
 Fibroblastic meningioma (1) F
 Psammomatous meningioma (1) F
 Meningothelial meningioma (1) F
  1. WHO World Health Organization, M male, F female